Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 136 member C, pseudogene (FAM136CP) is a pseudogene, meaning it is a nonfunctional copy of a gene and does not encode a protein product[1][3]. While pseudogenes were once considered "junk" DNA, some have regulatory RNA functions such as acting as microRNA decoys or influencing the stability and expression of related protein-coding genes[3]. There is currently no evidence that FAM136CP is involved in any specific biological process or disease, nor is it a known therapeutic target[1][3]. Note: - FAM136CP is classified as a pseudogene, not a protein-coding gene, receptor, enzyme, or other classical drug target[1][3]. - Many pseudogenes may influence gene regulation at the RNA level but are not conventionally considered therapeutic targets or biomarkers unless direct disease or functional evidence is established[3]. - No drugs, mechanisms of drug action, or specific clinical biomarkers are reported for FAM136CP[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 136 member C, pseudogene (FAM136CP).